JIANG ZHI JIAO NANG

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

ダウンロード 公開評価報告書 (PAR)
29-07-2019

有効成分:

Wolfiporia cocos, Quantity: 10.11 mg (Equivalent: Wolfiporia cocos, Qty 101.07 mg); Salvia miltiorrhiza, Quantity: 42.11 mg (Equivalent: Salvia miltiorrhiza, Qty 126.34 mg); Astragalus membranaceus, Quantity: 33.69 mg (Equivalent: Astragalus membranaceus, Qty 101.07 mg); Lonicera japonica, Quantity: 57.64 mg (Equivalent: Lonicera japonica, Qty 57.64 mg); Lonicera japonica, Quantity: 14.47 mg (Equivalent: Lonicera japonica, Qty 43.43 mg); Crataegus pinnatifida, Quantity: 63.17 mg (Equivalent: Crataegus pinna

から入手可能:

Herbal International Pty Ltd

医薬品形態:

Capsule, hard

構図:

Excipient Ingredients: Gelatin; titanium dioxide

投与経路:

Oral

適応症:

Traditionally used in Chinese medicine to eliminate/reduce/remove/resolve/dissipate blood-stasis

製品概要:

Visual Identification: ;

認証ステータス:

Listed

承認日:

2019-07-12

ドキュメントの履歴を表示する